Surgery for clinical T3 carcinomas of the upper thoracic oesophagus and the need for new strategies
Authors:
- 4 July 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 92 (10) , 1235-1240
Abstract
Background: Patients with T3 carcinomas have a dismal prognosis, even after complete resection of the primary tumour and metastatic nodes. This study focused on the clinicopathological characteristics and outcomes after surgical resection of clinical T3 carcinomas of the upper thoracic oesophagus. Methods: Between January 1988 and February 2000, 888 consecutive patients underwent surgical removal of carcinomas of the thoracic oesophagus or oesophagogastric junction at the National Cancer Centre Hospital, Japan. The case records of 51 consecutive patients with clinical T3 tumours of the upper thoracic oesophagus were analysed retrospectively. Results: No patient received preoperative therapy. Complications occurred in 41 (80 per cent). In‐hospital and 30‐day postoperative mortality rates were 10 and 4 per cent respectively. Gross residual primary tumour or metastasis in regional nodes invading adjacent structures was noted in 14 patients (27 per cent) and incomplete resection including microscopic residual tumour in 23 (45 per cent). Overall 3‐ and 5‐year survival rates were 20 and 12 per cent; median survival was 13·1 months. Conclusion: Surgical resection of clinical T3 carcinomas of the upper thoracic oesophagus is associated with a high postoperative complication rate, incomplete resection and unsatisfactory outcome. Reconsideration of the surgical treatment strategy for these tumours is needed. Copyright © 2005 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissectionSurgery, 2003
- Cervical lymphadenectomy is beneficial for patients with carcinoma of the upper and mid-thoracic esophagusDiseases of the Esophagus, 2003
- Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissectionEuropean Journal of Cardio-Thoracic Surgery, 2001
- Transhiatal Esophagectomy for Treatment of Benign and Malignant Esophageal DiseaseWorld Journal of Surgery, 2001
- Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomyThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- Can esophagectomy cure cancer of the thoracic esophagus involving the major airways?The Annals of Thoracic Surgery, 1995
- Radical Lymph Node Dissection for Cancer of the Thoracic EsophagusAnnals of Surgery, 1994
- Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinomaThe Annals of Thoracic Surgery, 1994